睾酮替代治疗制剂与翻修全膝关节置换术风险的潜在关联
回顾性队列分析男性性腺功能减退症合并全膝关节置换术患者,比较不同睾酮替代治疗制剂与翻修风险。最终队列62例中,6例(9.7%)发生翻修,肌注组翻修可能性高于外用组(卡方检验 P=0.046)。结论提示肌注睾酮替代治疗相比外用制剂可能与翻修全膝关节置换术风险增加相关。
要点
- 肌注睾酮替代治疗组翻修全膝关节置换术可能性高于外用组(卡方检验 P=0.046)。
- 最终队列62例中6例(9.7%)翻修:3例(4.8%)假体周围感染,3例(4.8%)无菌性松动。
- 肌注组平均血清睾酮652.6 ng/dL高于外用组356.1 ng/dL(P=0.001)。
核心结论
- 本研究提示接受肌注睾酮替代治疗的患者相比外用睾酮替代治疗患者,翻修全膝关节置换术的可能性增加。
- 作者认为调整围手术期全膝关节置换术患者的睾酮替代治疗制剂可能降低继发于感染的可改变翻修风险。
研究设计与样本
- 回顾性队列分析,在多医院卫生系统进行。
- 对性腺功能减退症合并全膝关节置换术患者进行病历审查。
- 纳入标准:男性,年龄18至89岁,有睾酮替代治疗处方,随访至少90天。
- 最终队列62例,分析睾酮替代治疗制剂、血清睾酮水平、合并症及全膝关节置换术翻修(感染性与非感染性翻修)。
- 使用社会科学统计软件包进行统计分析,P<0.05为显著性。
主要发现
- 最终队列62例中,33例(53.2%)使用外用睾酮替代治疗,27例(43.55%)使用肌注睾酮替代治疗,2例(3.2%)接受睾酮替代治疗埋植。
- 共6例(9.7%)发生全膝关节置换术翻修:3例(4.8%)为假体周围关节感染,3例(4.8%)为无感染性松动。
- 翻修病例中,5例在肌注睾酮替代治疗组,1例在外用睾酮替代治疗组。
- 肌注睾酮替代治疗组平均血清睾酮为652.6 ng/dL,高于外用睾酮替代治疗组的356.1 ng/dL(P=0.001)。
- 卡方分析显示肌注组相比外用睾酮替代治疗组翻修可能性增加[卡方(1, N=60)=3.96, P=0.046]。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Testosterone replacement therapy (TRT) is a commonly utilized treatment for male hypogonadism. Prescriptions for TRT are available in various formulations, including creams, gels, solutions, patches, intramuscular injections, and subcutaneous pellet implantation. Prior work identified the correlation between TRT and revision rotator cuff and quadriceps tendon rupture repair. The risk associated with TRT and total knee arthroplasty (TKA) is not currently delineated. This investigation sought to identify the relationship between TRT and revision TKA. METHODS: Retrospective cohort analysis was conducted at a multihospital health system. Chart review of patients with hypogonadism and TKA was performed. Inclusion criteria included men aged 18 to 89 years, TRT prescription, and follow-up of at least 90 days. Analysis included TRT formulation, serum testosterone level, comorbidities, and analysis of TKA revision (septic versus aseptic revision). Statistical Package for Social Sciences was utilized to identify the significance of findings, P < 0.05. RESULTS: Within the final cohort of 62 patients, 33 (53.2%) utilized topical TRT, 27 (43.55%) utilized injectable IM TRT, and two (3.2%) underwent implantation of a TRT pellet. There were six (9.7%) TKA revisions: three (4.8%) were for periprosthetic joint infection and three (4.8%) due to loosening without infection. Of revisions, five were in the IM TRT group and 1 in the topical TRT group. Average testosterone serum was higher for patients who had IM TRT (652.6 ng/dL) than topical TRT (356.1 ng/dL) (P = 0.001). Chi-square analysis determined increased likelihood of revision in the IM group compared to topical TRT group [Chi-square (1, N = 60) = 3.96, P = 0.046]. CONCLUSIONS: This study suggests increased likelihood of TKA revision in patients undergoing TRT with IM formulation compared to topical TRT formulations. Modification of the TRT formulation in the perioperative TKA patient may provide a reduction in a modifiable risk for revision TKA secondary to infection.
引用
- Ganz MP, Cohn RM, Scuderi GR, et al. Testosterone Replacement Therapy Formulation and Potential Association With Risk of Revision Total Knee Arthroplasty. J Arthroplasty. 2025. PMID: 40451549. doi:10.1016/j.arth.2025.05.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。